Ra Pharmaceuticals

World Rank (Jul-30-2023)

21,723

Market Cap (Jul-30-2023)

0.099 Billion USD

World Rank (Jan-07-2022)

22,472

Market Cap (Jan-07-2022)

0.108 Billion USD

World Rank (Jan-01-2021)

4,772

Headquarters Country

Headquarters City/State

World Region

World Subregion

Business Sector

Company Website

Company Profile

Ra Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The headquarters is in USA.

UCB acquired Ra Pharmaceuticals for 2.1 Billion USD as on 2019.

IPO Year

2016

Stock Exchange

World Top Companies